Next Article in Journal
A Bioinformatics Model of Human Diseases on the Basis of Differentially Expressed Genes (of Domestic Versus Wild Animals) That Are Orthologs of Human Genes Associated with Reproductive-Potential Changes
Previous Article in Journal
Metabolic Analysis of Vitreous/Lens and Retina in Wild Type and Retinal Degeneration Mice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 5
10.3390/ijms22052343
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Int. J. Mol. Sci. 2013, 14(10), 20543-20554.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554

by
Yan Li
1,
Ying Luo
2,
Xuerong Zhang
2,
Xing Lin
2,
Min He
2 and
Ming Liao
2,*
1
College of Animal Science and Technology, Guangxi University, Nanning 530004, China
2
Medical Scientific Research Center, Guangxi Medical University, Nanning 530021, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(5), 2343; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22052343
Submission received: 12 January 2021 / Accepted: 14 January 2021 / Published: 26 February 2021
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Browse Figures
Versions Notes
The authors regret that, during the preparation of our published manuscript “Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors” [1], we submitted an incorrect version of Figure 2. Thus, Figure 2 should be replaced with the following figure (Figure 1).
The correction does not change the scientific conclusions of the article in any way. The authors apologize for any confusion this error may have caused to the readers.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Li, Y.; Luo, Y.; Zhang, X.; Lin, X.; He, M.; Liao, M. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ijms 22 02343 g001a 550Ijms 22 02343 g001b 550
Figure 1. The mRNA expression levels of genes associated with hepatic fibrogenesis in HSC-T6 cells treated with a combination of taurine, EGCG and genistein. Semi-quantitative PCR data are shown for cells treated with a combination of taurine, EGCG and genistein in varying doses. The relative mRNA expression levels of TGF-β1 (A), Col-I (B), TIMP-1 (C), TIMP-2 (D), and MMP-2 (E) are presented; the upper panels show representative pictures of agarose gels and the lower panels show relative quantification of mRNA expression levels in (I) untreated control cells, or cells treated with (II) 0.015 mg/mL taurine, 0.0175 mg/mL EGCG and 0.0035 mg/mL genistein, (III) 0.03 mg/mL taurine, 0.035 mg/mL EGCG and 0.007 mg/mL genistein, or (IV) 0.06 mg/mL taurine, 0.07 mg/mL EGCG and 0.014 mg/mL genistein. (M) Marker. Data are presented as the mean ± S.E.; * p < 0.05 vs. group I (untreated control).
Figure 1. The mRNA expression levels of genes associated with hepatic fibrogenesis in HSC-T6 cells treated with a combination of taurine, EGCG and genistein. Semi-quantitative PCR data are shown for cells treated with a combination of taurine, EGCG and genistein in varying doses. The relative mRNA expression levels of TGF-β1 (A), Col-I (B), TIMP-1 (C), TIMP-2 (D), and MMP-2 (E) are presented; the upper panels show representative pictures of agarose gels and the lower panels show relative quantification of mRNA expression levels in (I) untreated control cells, or cells treated with (II) 0.015 mg/mL taurine, 0.0175 mg/mL EGCG and 0.0035 mg/mL genistein, (III) 0.03 mg/mL taurine, 0.035 mg/mL EGCG and 0.007 mg/mL genistein, or (IV) 0.06 mg/mL taurine, 0.07 mg/mL EGCG and 0.014 mg/mL genistein. (M) Marker. Data are presented as the mean ± S.E.; * p < 0.05 vs. group I (untreated control).
Ijms 22 02343 g001aIjms 22 02343 g001b
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Li, Y.; Luo, Y.; Zhang, X.; Lin, X.; He, M.; Liao, M. Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554. Int. J. Mol. Sci. 2021, 22, 2343. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22052343

AMA Style

Li Y, Luo Y, Zhang X, Lin X, He M, Liao M. Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554. International Journal of Molecular Sciences. 2021; 22(5):2343. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22052343

Chicago/Turabian Style

Li, Yan, Ying Luo, Xuerong Zhang, Xing Lin, Min He, and Ming Liao. 2021. "Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554" International Journal of Molecular Sciences 22, no. 5: 2343. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22052343

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop